Director, Duke ALS Clinic
Department / Division
Neurology / Neurology Chair
Durham, NC 27710
Amyotrophic lateral sclerosis and other motor neuron diseases
1. Investigator-initiated and multi-center clinical trials testing new treatments for amyotrophic lateral sclerosis and diabetic neuropathy.
2. Epidemiologic studies to better understand the causes and variability in prognosis of amyotrophic lateral sclerosis and diabetic neuropathy.
3. Basic science studies to develop novel biomarkers for amyotrophic lateral sclerosis.
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
Bedlack, RS; Traynor, BJ; Cudkowicz, ME. Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opinion on Emerging Drugs. 2007;12:229-252. (2007) Abstract
Gordon, PH; Moore, DH; Miller, RG; Florence, JM; Verheijde, JL; Doorish, C; Hilton, JF; Spitalny, GM; MacArthur, RB; Mitsumoto, H; Neville, HE; Boylan, K; Mozaffar, T; Belsh, JM; Ravits, J; Bedlack, RS; Graves, MC; McCluskey, LF; Barohn, RJ; Tandan, R; Western ALS Study Group. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurology. 2007;6:1045-1053. (2007) Abstract